project id: TCGA-LGG; case submitter id: TCGA-FG-A711; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.89; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.14; rna integrity number: 7.8; age at index: 33; days to birth: -12248; days to death: 1481; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1977; age at diagnosis: 12248; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1329.0; icd 10 code: C71.0; last known disease status: not reported; morphology: 9450/3; primary diagnosis: Oligodendroglioma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cerebrum; synchronous malignancy: No; tissue or organ of origin: Cerebrum; tumor grade: Not Reported; year of diagnosis: 2010; alcohol history: Not Reported; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 1265; days to sample procurement: 0; initial weight: 410.0; portion submitter id: TCGA-FG-A711-01A-21; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 10.0; percent stromal cells: 40.0; percent tumor cells: 50.0; percent tumor nuclei: 75.0;